Assenagon Asset Management S.A. Has $80.66 Million Stock Holdings in CME Group Inc. $CME

Key Points

• Assenagon Asset Management increased its CME Group stake by 48.7% in the second quarter, purchasing 119,619 additional shares. Institutional investors and hedge funds collectively own 87.75% of CME’s stock.
• Analyst sentiment remains mixed: 11 analysts rate CME a Buy, four rate it Hold and three rate it Sell. The stock has an average rating of “Hold” and an average price target of $291.81.
• CME exceeded quarterly expectations with $2.99 in earnings per share and $1.71 billion in revenue, while declaring a quarterly dividend of $1.30 per share, equivalent to a 2.0% annual yield.

Assenagon Asset Management S.A. raised its position in CME Group Inc. (NASDAQ:CME - Free Report) by 48.7% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 365,248 shares of the financial services provider's stock after purchasing an additional 119,619 shares during the period. Assenagon Asset Management S.A. owned approximately 0.10% of CME Group worth $80,658,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of CME. Sarasin & Partners LLP boosted its holdings in shares of CME Group by 41.2% in the second quarter. Sarasin & Partners LLP now owns 1,314,268 shares of the financial services provider's stock valued at $290,230,000 after buying an additional 383,581 shares during the period. Martin Capital Partners LLC lifted its stake in CME Group by 27.1% in the 2nd quarter. Martin Capital Partners LLC now owns 40,121 shares of the financial services provider's stock valued at $8,860,000 after purchasing an additional 8,549 shares during the last quarter. Grant Private Wealth Management Inc increased its holdings in shares of CME Group by 43.7% during the 2nd quarter. Grant Private Wealth Management Inc now owns 1,848 shares of the financial services provider's stock worth $408,000 after acquiring an additional 562 shares during the last quarter. Arlington Partners LLC grew its stake in CME Group by 6.2% in the 2nd quarter. Arlington Partners LLC now owns 843 shares of the financial services provider's stock valued at $186,000 after buying an additional 49 shares during the last quarter. Finally, Harbor Investment Advisory LLC boosted its holdings in shares of CME Group by 172.8% during the second quarter. Harbor Investment Advisory LLC now owns 221 shares of the financial services provider's stock worth $49,000 after acquiring an additional 140 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have recently commented on CME. TD Cowen lowered their target price on shares of CME Group from $323.00 to $273.00 and set a "buy" rating on the stock in a report on Monday, June 22nd. Barclays dropped their target price on CME Group from $316.00 to $270.00 and set an "equal weight" rating for the company in a research report on Thursday, July 9th. Erste Group Bank lowered CME Group from a "buy" rating to a "hold" rating in a research note on Friday, June 5th. UBS Group reduced their price target on CME Group from $310.00 to $260.00 and set a "buy" rating on the stock in a report on Monday, July 6th. Finally, Keefe, Bruyette & Woods raised CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price objective for the company in a research note on Thursday, June 18th. Eleven analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Hold" and an average target price of $291.81.

Insider Buying and Selling

In other CME Group news, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction that occurred on Friday, May 15th. The stock was sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company's stock, valued at approximately $16,606,111.30. The trade was a 38.62% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William R. Shepard bought 325 shares of the stock in a transaction dated Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. 0.30% of the stock is owned by insiders.

CME Group Stock Down 0.2%

CME stock opened at $263.66 on Friday. The company has a market capitalization of $94.81 billion, a price-to-earnings ratio of 22.36, a PEG ratio of 3.08 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a fifty day moving average of $249.24 and a 200-day moving average of $280.78. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts' consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company's quarterly revenue was up .8% compared to the same quarter last year. During the same period in the prior year, the company earned $2.96 EPS. As a group, equities research analysts predict that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a dividend yield of 2.0%. CME Group's payout ratio is currently 44.11%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source